ABSTRACT
OBJECTIVES: This study aimed to determine the impact of the approval of prothrombin complex concentrates on the treatment of vitamin K antagonist-related intracerebral hemorrhage. MATERIALS AND METHODS: We retrospectively studied all patients with vitamin K antagonist-related intracerebral hemorrhage treated with prothrombin complex concentrate at our institutes between January 2010 and June 2021. Before approval, prothrombin complex concentrate was administered as either 500 or 1000 IU at the physician's discretion (previous dose group). After approval, we adopted the manufacturer's recommended regimen (recommended dose group). The primary outcome was post-administration international normalized ratio. Secondary outcomes were the amount of prothrombin complex concentrate administered and proportion of post-administration international normalized ratio <1.5, hematoma expansion, thrombotic events within 30 days, modified Rankin scale 0-3 at discharge, and in-hospital mortality. RESULTS: Thirty-two and 19 patients in the previous and recommended dose groups, respectively, were included. The post-administration international normalized ratio significantly differed between groups. The prothrombin complex concentrate dose and proportion of patients achieving post-administration international normalized ratio <1.5 were significantly higher in the recommended dose group than in the previous dose group (1500 IU vs. 500 IU, p<0.001 and 100% vs. 68%, p = 0.008). The proportions of hematoma expansion, thromboembolic events, modified Rankin scale 0-3, and mortality did not differ between groups. CONCLUSION: After prothrombin complex concentrate approval, prothrombin time-international normalized ratio correction was more effective with a significant increase in the prothrombin complex concentrates dose for vitamin K antagonist-associated intracerebral hemorrhage; however, there was no apparent difference in clinical outcomes.
Subject(s)
Prothrombin , Vitamin K , Humans , Retrospective Studies , Prothrombin/therapeutic use , Blood Coagulation Factors/adverse effects , Anticoagulants/adverse effects , International Normalized Ratio , Cerebral Hemorrhage/chemically induced , Cerebral Hemorrhage/drug therapy , Hematoma/drug therapy , Fibrinolytic Agents/therapeutic useABSTRACT
BACKGROUND AND PURPOSE: High blood pressure increases bleeding risk during treatment with antithrombotic medication. The association between blood pressure levels and the risk of recurrent stroke during long-term secondary stroke prevention with thienopyridines (particularly prasugrel) has not been well studied. METHODS: This was a post hoc analysis of the randomized, double-blind, multicenter PRASTRO-I trial (Comparison of Prasugrel and Clopidogrel in Japanese Patients With Ischemic Stroke-I). Patients with noncardioembolic stroke were randomly assigned (1:1) to receive prasugrel 3.75 mg/day or clopidogrel 75 mg/day for 96 to 104 weeks. Risks of any ischemic or hemorrhagic stroke, combined ischemic events, and combined bleeding events were determined based on the mean level and visit-to-visit variability, including successive variation, of systolic blood pressure (SBP) throughout the observational period. These risks were also compared between quartiles of mean SBP level and successive variation of SBP. RESULTS: A total of 3747 patients (age 62.1±8.5 years, 797 women), with a median average SBP level during the observational period of 132.5 mm Hg, were studied. All the risks of any stroke (146 events; hazard ratio, 1.318 [95% CI, 1.094-1.583] per 10-mm Hg increase), ischemic stroke (133 events, 1.219 [1.010-1.466]), hemorrhagic stroke (13 events, 3.247 [1.660-6.296]), ischemic events (142 events, 1.219 [1.020-1.466]), and bleeding events (47 events, 1.629 [1.172-2.261]) correlated with increasing mean SBP overall. Similarly, an increased risk of these events correlated with increasing successive variation of SBP (hazard ratio, 3.078 [95% CI, 2.220-4.225] per 10-mm Hg increase; 3.051 [2.179-4.262]; 3.276 [1.172-9.092]; 2.865 [2.042-4.011]; 2.764 [1.524-5.016], respectively). Event rates did not differ between the clopidogrel and prasugrel groups within each quartile of SBP or successive variation of SBP. CONCLUSIONS: Both high mean SBP level and high visit-to-visit variability in SBP were significantly associated with the risk of recurrent stroke during long-term medication with either prasugrel or clopidogrel after stroke. Control of hypertension would be important regardless of the type of antiplatelet drugs. Registration: URL: https://www.clinicaltrials.jp; Unique identifier: JapicCTI-111582.
Subject(s)
Clopidogrel/therapeutic use , Hypertension/complications , Ischemic Stroke/complications , Ischemic Stroke/drug therapy , Prasugrel Hydrochloride/therapeutic use , Aged , Blood Pressure , Double-Blind Method , Female , Humans , Male , Middle Aged , Platelet Aggregation Inhibitors/therapeutic use , Secondary Prevention/methods , Thromboembolism/prevention & controlABSTRACT
PURPOSE: Endovascular treatment of unruptured intracranial aneurysms may increase cerebral microbleeds (CMBs) in postprocedural T2*-weighted MRIs, which may be a risk for future intracerebral hemorrhage. This study examined the characteristics of postprocedural CMBs and the factors that cause their increase. METHODS: The patients who underwent endovascular treatment for unruptured intracranial aneurysms from April 2016 to February 2018 were retrospectively analyzed. Treatment techniques for endovascular treatment included simple coiling, balloon-assisted coiling, stent-assisted coiling, or flow diverter placement. To evaluate the increase in CMBs, a head MRI including diffusion-weighted imaging and T2*-weighted MRIs was performed on the preprocedural day; the first postprocedural day; and at 1, 3, and 6 months after the procedure. RESULTS: Among the 101 aneurysms that were analyzed, 38 (37.6%) showed the appearance of new CMBs. In the multivariate analysis examining the causes of the CMB increases, chronic kidney disease, a higher number of preprocedural CMBs, and a higher number of diffusion-weighted imaging-positive lesions on the first postprocedural day were independent risk factors. Furthermore, a greater portion of the increased CMBs was found in cortical and subcortical lesions of the treated vascular perfusion area within 1 month after the procedure. CONCLUSION: In endovascular treatment for unruptured intracranial aneurysms, CMBs tended to increase in patients with small vessel disease before the procedure, and it was also implicated in hemorrhagic changes after periprocedural microinfarction.
Subject(s)
Embolization, Therapeutic , Endovascular Procedures , Intracranial Aneurysm , Cerebral Hemorrhage/diagnostic imaging , Cerebral Hemorrhage/etiology , Embolization, Therapeutic/adverse effects , Endovascular Procedures/adverse effects , Humans , Intracranial Aneurysm/diagnostic imaging , Intracranial Aneurysm/therapy , Retrospective Studies , Treatment OutcomeABSTRACT
The original version of this article unfortunately contained an error in affiliation of Yuhtaka Fukuda.
ABSTRACT
OBJECTIVE: We report a case of a 70-year-old man who developed a transverse-sigmoid dural arteriovenous fistula (TS-DAVF) that was successfully treated by transarterial embolization (TAE) with Onyx. CASE PRESENTATION: The patient presented with sudden and progressive disturbance of consciousness and left hemiparesis. Magnetic resonance imaging (MRI) revealed venous infarction and hemorrhagic changes with brain swelling in the right parietal lobe. Angiography revealed a right TS-DAVF and multiple occlusions with retrograde leptomeningeal venous drainage into the cortical veins. The TS-DAVF was graded as Borden type III and Cognard type IIa+b. Because of its progressive clinical nature and wide distribution of DAVF in the occluded sinus wall, he underwent emergent TAE with liquid embolic materials including n-butyl cyanoacrylate and Onyx under informed consent by his family. Complete obliteration of the TS-DAVF was achieved, leading to a marked amelioration of symptoms, and MRI after treatment confirmed a decrease in the brain swelling. However, he suffered transient dysphagia due to right vagal nerve palsy caused by occlusion of vasa nervorum of ascending pharyngeal artery. He returned home 5 months later with a modified Rankin Scale of 1. CONCLUSIONS: TAE with Onyx appears to be effective for aggressive TS-DAVF with a widely distributed shunt. However, the blood supply to the cranial nerves and potentially dangerous anastomoses between the external-internal carotid artery and vertebral artery should be taken into account to avoid serious complications.
Subject(s)
Central Nervous System Vascular Malformations/therapy , Deglutition Disorders/etiology , Embolization, Therapeutic/adverse effects , Paralysis/etiology , Polyvinyls/adverse effects , Tantalum/adverse effects , Vagus Nerve Diseases/etiology , Vagus Nerve/physiopathology , Aged , Central Nervous System Vascular Malformations/diagnostic imaging , Central Nervous System Vascular Malformations/physiopathology , Cerebral Angiography , Deglutition Disorders/diagnosis , Deglutition Disorders/physiopathology , Deglutition Disorders/therapy , Drug Combinations , Humans , Magnetic Resonance Imaging , Male , Paralysis/diagnosis , Paralysis/physiopathology , Paralysis/therapy , Polyvinyls/administration & dosage , Recovery of Function , Tantalum/administration & dosage , Treatment Outcome , Vagus Nerve Diseases/diagnosis , Vagus Nerve Diseases/physiopathology , Vagus Nerve Diseases/therapyABSTRACT
BACKGROUND: Although the Brain Attack Coalition recommended establishing centers of comprehensive care for stroke and cerebrovascular disease patients, a scoring system for such centers was lacking. We created and validated a comprehensive stroke center (CSC) score, adapted to Japanese circumstances. METHODS: Of the selected 1369 certified training institutions in Japan, 749 completed an acute stroke care capabilities survey. Hospital performance was determined using a 25-item score, evaluating 5 subcategories: personnel, diagnostic techniques, specific expertise, infrastructure, and education. Consistency and validity were examined using correlation coefficients and factorial analysis. RESULTS: The CSC score (median, 14; interquartile range, 11-18) varied according to hospital volume. The five subcategories showed moderate consistency (Cronbach's α = 0.765). A strong correlation existed between types of available personnel and specific expertise. Using the 2011 Japanese Diagnosis Procedure Combination database for patients hospitalized with stroke, four constructs were identified by factorial analysis (neurovascular surgery and intervention, vascular neurology, diagnostic neuroradiology, and neurocritical care and rehabilitation) that affected in-hospital mortality from ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. The total CSC score was related to in-hospital mortality from ischemic stroke (odds ratio [OR], 0.973; 95% confidence interval [CI], 0.958-0.989), intracerebral hemorrhage (OR, 0.970; 95% CI, 0.950-0.990), and subarachnoid hemorrhage (OR, 0.951; 95% CI, 0.925-0.977), with varying contributions from the four constructs. CONCLUSIONS: The CSC score is a valid measure for assessing CSC capabilities, based on the availability of neurovascular surgery and intervention, vascular neurology, diagnostic neuroradiology, and critical care and rehabilitation services.
Subject(s)
Cerebral Hemorrhage/therapy , Hospitals/standards , Stroke/therapy , Subarachnoid Hemorrhage/therapy , Adolescent , Adult , Aged , Aged, 80 and over , Brain Ischemia/diagnosis , Brain Ischemia/therapy , Cerebral Hemorrhage/mortality , Cerebrovascular Disorders/therapy , Databases, Factual , Female , Hospital Mortality , Humans , Japan , Male , Middle Aged , Stroke/diagnosis , Subarachnoid Hemorrhage/mortality , Young AdultABSTRACT
AIM: Impaired social functioning is a common characteristic of patients with schizophrenia. Social functioning requires the complex operation of various executive functions. Deficits in the prefrontal cortex (PFC) have been implicated in executive dysfunction. Here we aimed to clarify the relation between subjectively and objectively assessed social functioning, and their associations with PFC function in patients with schizophrenia. METHODS: Twenty-three patients and 22 age- and sex-matched healthy controls (HC) were assessed. In the schizophrenia group, self- and caregiver-rated social functioning were measured using the Specific Level of Functioning Assessment (SLOF). The hemodynamic responses elicited by a verbal fluency task (VFT) in three regions of interest in the frontotemporal area were measured using multi-channel near-infrared spectroscopy (NIRS). We also investigated psychiatric symptoms, neurocognition, and cognitive insight to assess possible confounding factors. RESULTS: Significant positive correlations were found between self- and caregiver-rated SLOF composite scores and three subdomain scores. Self- and caregiver-rated SLOF composite scores were significantly associated with dorsolateral PFC and frontopolar cortex (DLPFC/FPC) activation during the VFT. Psychiatric symptoms, global functioning, neurocognition, and cognitive insight were not associated with NIRS signals. General psychopathology was associated with NIRS signals in the ventrolateral PFC and the anterior temporal cortex. DLPFC and FPC activity may be associated with social functioning in patients with schizophrenia. CONCLUSION: Our results suggest that the two distinct assessments of social functioning were significantly correlated. Moreover, DLPFC and FPC function was strongly associated with social functioning and the ability to carry out daily life in patients with schizophrenia.
Subject(s)
Frontal Lobe/physiopathology , Prefrontal Cortex/physiopathology , Schizophrenia/physiopathology , Social Adjustment , Adult , Aged , Case-Control Studies , Cognition/physiology , Female , Hemodynamics/physiology , Humans , Male , Middle Aged , Neuropsychological Tests , Schizophrenic Psychology , Spectroscopy, Near-Infrared , Verbal Behavior/physiology , Young AdultABSTRACT
Candesartan has been reported to have a protective effect on cerebral ischemia in vivo and in human ischemic stroke. We studied the direct effects of candesartan on blood-brain barrier (BBB) function with our in vitro monolayer model generated using rat brain capillary endothelial cells (RBECs). The in vitro BBB model was subjected to normoxia or 6-h oxygen glucose deprivation (OGD)/24-h reoxygenation, with or without candesartan. 6-h OGD/24-h reoxygenation decreased transendothelial electrical resistance and increased the endothelial permeability for sodium fluorescein in RBEC monolayers. Candesartan (10 nM) improved RBEC barrier dysfunction induced by 6-h OGD/24-h reoxygenation. Immunostaining and immunoblotting analysis indicated that the effect of candesartan on barrier function under 6-h OGD/24-h reoxygenation was not related to the expression levels of tight junction proteins. However, candesartan affected RBEC morphological changes induced by 6-h OGD/24-h reoxygenation. We analyzed oxidative stress and cell viability using chemical reagents. Candesartan improved cell viability following 6-h OGD/24-h reoxygenation, whereas candesartan had no effect on oxidative stress. These results show that candesartan directly improves cell function and viability of brain capillary endothelial cells under OGD/reoxygenation, suggesting that the protective effects of candesartan on ischemic stroke are related to protection of the BBB.
Subject(s)
Benzimidazoles/pharmacology , Blood-Brain Barrier/pathology , Brain Ischemia/pathology , Tetrazoles/pharmacology , Animals , Biphenyl Compounds , Blood-Brain Barrier/drug effects , Cell Survival/drug effects , Electric Impedance , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Endothelial Cells/pathology , Nitrates/metabolism , Nitrites/metabolism , Rats, Wistar , Reactive Oxygen Species/metabolism , Tight Junction Proteins/metabolism , Tight Junctions/drug effects , Tight Junctions/metabolismABSTRACT
Cell transplantation therapy for cerebral infarction has emerged as a promising treatment to reduce brain damage and enhance functional recovery. We previously reported that intra-arterial delivery of bone marrow mesenchymal stem cells (MSCs) enables superselective cell administration to the infarct area and results in significant functional recovery after ischemic stroke in a rat model. However, to reduce the risk of embolism caused by the transplanted cells, an optimal cell number should be determined. At 24 h after middle cerebral artery occlusion and reperfusion, we administered human MSCs (low dose: 1 × 10(4) cells; high dose: 1 × 10(6) cells) and then assessed functional recovery, inflammatory responses, cell distribution, and mortality. Rats treated with high- or low-dose MSCs showed behavioral recovery. At day 8 post-stroke, microglial activation was suppressed significantly, and interleukin (IL)-1ß and IL-12p70 were reduced in both groups. Although high-dose MSCs were more widely distributed in the cortex and striatum of rats, the degree of intravascular cell aggregation and mortality was significantly higher in the high-dose group. In conclusion, selective intra-arterial transplantation of low-dose MSCs has anti-inflammatory effects and reduces the adverse effects of embolic complication, resulting in sufficient functional recovery of the affected brain.
Subject(s)
Mesenchymal Stem Cell Transplantation/methods , Recovery of Function , Stroke/therapy , Animals , Cells, Cultured , Female , Humans , Infusions, Intra-Arterial , Male , Mesenchymal Stem Cell Transplantation/adverse effects , Rats , Rats, Sprague-Dawley , Stroke/mortality , Stroke/pathology , Young AdultABSTRACT
We investigated the effects of cilostazol, a selective inhibitor of phosphodiesterase 3, on blood-brain barrier (BBB) integrity against ischemia-reperfusion injury enhanced by advanced glycation endproducts (AGEs). We used in vitro BBB models with primarily cultured BBB-related cells from rats (brain capillary endothelial cells, astrocytes and pericytes), and subjected cells to either normoxia or 3-h oxygen glucose deprivation (OGD)/24-h reoxygenation with or without AGEs. Treatment of AGEs did not affect the transendothelial electrical resistance (TEER) in the BBB model under normoxia, but there was a significant decrease in TEER under 3-h OGD/24-h reoxygenation conditions with AGEs. Cilostazol inhibited decreases in TEER induced by 3-h OGD/24-h reoxygenation with AGEs. Immunocytochemical and Western blot analyses showed that AGEs reduced the expression of claudin-5, the main functional protein of tight junctions (TJs). In contrast, cilostazol increased the expression of claudin-5 under 3-h OGD/24-h reoxygenation with AGEs. Furthermore, while AGEs increased the production of extracellular transforming growth factor (TGF)-ß1, cilostazol inhibited the production of extracellular TGF-ß1 and restored the integrity of TJs. Thus, we found that AGEs enhanced ischemia-reperfusion injury, which mainly included decreases in the expression of proteins comprising TJs through the production of TGF-ß1. Cilostazol appeared to limit ischemia-reperfusion injury with AGEs by improving the TJ proteins and inhibiting TGF-ß1 signaling.
Subject(s)
Blood-Brain Barrier/drug effects , Cell Hypoxia , Glycation End Products, Advanced/metabolism , Pericytes/metabolism , Phosphodiesterase 3 Inhibitors/pharmacology , Tetrazoles/pharmacology , Transforming Growth Factor beta1/metabolism , Animals , Astrocytes/drug effects , Astrocytes/metabolism , Blood-Brain Barrier/metabolism , Capillary Permeability , Cells, Cultured , Cilostazol , Claudin-5/genetics , Claudin-5/metabolism , Electric Impedance , Pericytes/drug effects , Rats , Rats, Wistar , Reperfusion Injury/metabolism , Signal Transduction , Tight Junctions/drug effects , Tight Junctions/metabolismABSTRACT
BACKGROUND AND PURPOSE: The ivy sign on fluid-attenuated inversion recovery MRI is a specific finding in moyamoya disease (MMD). This sign indicates decreased cerebral perfusion, dilated pial vasculature, and slow leptomeningeal collateral flow. This study aimed to clarify the characteristics of perioperative changes in the ivy sign in relation to cerebral hyperperfusion, which frequently occurs in MMD of unknown pathogenesis. METHODS: This prospective study included patients with MMD who underwent superior temporal artery-middle cerebral artery single bypass. Fluid-attenuated inversion recovery MRI was performed to evaluate the appearance of the ivy sign in the ipsilateral hemisphere preoperatively and on postoperative days 2 and 30. The ivy sign was assessed in combination with perioperative symptoms and cerebral hemodynamics using single-photon emission computed tomography. RESULTS: Of 42 consecutive patients (55 sides) who underwent bypass surgery, 32 (58.2%) showed an increase in the ivy sign (de novo ivy sign) on postoperative day 2; this had disappeared by day 30. Interestingly, these 32 patients had a significantly higher incidence of hyperperfusion on single-photon emission computed tomography and hyperperfusion syndrome, and there was no correlation between the de novo ivy sign and a preoperative ivy sign or the preoperative cerebral hemodynamics. In multivariate analysis, a de novo ivy sign was significantly correlated with postoperative hyperperfusion. CONCLUSIONS: In MMD, a de novo ivy sign could indicate postoperative hyperperfusion after bypass, which is not always correlated with preoperative hemodynamic impairment. Additional factors other than preoperative cerebral hemodynamics might be involved in postoperative hyperperfusion in MMD.
Subject(s)
Cerebral Revascularization/adverse effects , Cerebrovascular Circulation/physiology , Magnetic Resonance Imaging/methods , Moyamoya Disease , Postoperative Complications/physiopathology , Cerebral Revascularization/methods , Female , Humans , Male , Middle Cerebral Artery/surgery , Moyamoya Disease/pathology , Moyamoya Disease/physiopathology , Moyamoya Disease/surgery , Postoperative Complications/pathology , Prospective Studies , Temporal Arteries/surgery , Tomography, Emission-Computed, Single-Photon , Treatment OutcomeABSTRACT
OBJECTIVES: Moyamoya disease (MMD) is a unique occlusive disease of the bilateral internal carotid arteries with moyamoya vessels. Inherited or acquired disorders and conditions may present in conjunction with MMD. This condition is known as quasi-moyamoya disease. To identify the clinical features of quasi-MMD in Japan, a nationwide survey was conducted. PATIENTS AND METHODS: A questionnaire was mailed directly to 241 departments that had acknowledged treating quasi-MMD patients in the primary survey. We ascertained the sex, age, family history, clinical manifestation, radiological findings, treatments, course of the disease, and daily activity of the patients. RESULTS: A total of 114 departments replied to the questionnaire. The data of 108 patients (66 female and 42 male; female to male ratio 1.57) were registered and analyzed. Mean age was 30.6 years old, with a peak in children. Seven patients (7 %) exhibited familial MMD. The initial clinical manifestation was motor weakness, followed by transient ischemic attack and headache. Their imaging study type included ischemic type in 64 patients (63.4 %), bleeding type in seven (6.9 %), and normal in 27 (26.7 %). Stenoocclusive lesion was seen in the internal carotid artery in more than half of the patients. Development of moyamoya vessels was mild in approximately 40 % of the patients. Almost all cases were accompanied by cerebral hypoperfusion. About half of them were unilateral lesion. Vascular reconstruction was employed for the approximately 60 % patients. The prognosis did not change significantly. CONCLUSION: Clinical features of quasi-MMD were revealed in the nationwide study. In quasi-MMD, unilateral lesion is dominant, and the development of moyamoya vessels and intracranial hemorrhage are less dominant.
Subject(s)
Intracranial Hemorrhages/etiology , Ischemic Attack, Transient/etiology , Moyamoya Disease/complications , Muscle Weakness/etiology , Seizures/etiology , Adolescent , Adult , Aged , Anterior Cerebral Artery/diagnostic imaging , Asymptomatic Diseases , Carotid Artery, Internal/diagnostic imaging , Cerebral Angiography , Child , Child, Preschool , Cohort Studies , Comorbidity , Female , Humans , Infant , Japan/epidemiology , Male , Middle Aged , Middle Cerebral Artery/diagnostic imaging , Moyamoya Disease/diagnosis , Moyamoya Disease/epidemiology , Surveys and Questionnaires , Young AdultABSTRACT
BACKGROUND: Postoperative cerebral hyperperfusion (HP) is a notable complication that occurs more frequently in moyamoya disease (MMD) than in atherosclerosis. This study aimed to clarify the characteristics of intraoperative indocyanine green (ICG) videoangiography in MMD and atherosclerotic disease in terms of postoperative HP. METHODS: This prospective study included 47 patients with 60 sides that underwent superior temporal artery (STA)-middle cerebral artery (MCA) single bypass. ICG videoangiography was performed after revascularization. The ICG time intensity curve was recorded in the STA, proximal MCA, distal MCA, and superficial Sylvian vein, and the angiographic differences among adult MMD, pediatric MMD, and atherosclerosis were analyzed. RESULTS: Twenty-two patients (27 sides) had adult MMD, 14 patients (22 sides) had pediatric MMD, and 11 patients (11 sides) had atherosclerosis. Postoperative HP was significantly higher in adult MMD (40.7 %) than in pediatric MMD (18.2 %) and atherosclerosis (0 %). Adult MMD with HP was associated with a longer ICG peak time (P < 0.001). There was no correlation between the ICG peak time and preoperative cerebral blood flow or vascular reserve. The ratio of the vessel caliber was also higher in adult MMD with HP (P < 0.001). CONCLUSIONS: ICG videoangiography provides different characteristics of bypass flow among adult MMD, pediatric MMD, and atherosclerosis. Poor run-off and stagnation of blood flow from the STA might contribute to postoperative HP in MMD. The occurrence of postoperative HP in MMD could depend on two factors: donor STA size and poor run-off and integrity of the blood brain barrier in the recipient MCA.
Subject(s)
Cerebral Angiography/methods , Cerebral Revascularization/methods , Cerebrovascular Circulation , Coloring Agents , Indocyanine Green , Intracranial Arteriosclerosis/surgery , Intraoperative Complications/diagnosis , Moyamoya Disease/surgery , Adolescent , Adult , Aged , Child , Child, Preschool , Female , Hemodynamics , Humans , Male , Middle Aged , Middle Cerebral Artery/surgery , Prospective Studies , Temporal Arteries/surgery , Video Recording/methods , Young AdultABSTRACT
Here we describe a case of iliac artery injury during carotid artery stenting (CAS) treated by covered stent. A 74-year-old man underwent CAS for asymptomatic right carotid artery stenosis. Under local anesthesia, the right common femoral artery was punctured and an 8 Fr long sheath introducer was placed. However, the sheath kinked because the iliac artery was tortuous. We introduced the stylet to the sheath again and tried to extend the kinking. It failed, and the arterial dissection was identified at the lateral iliac artery. The kink was extended with triple coaxial system, i.e. guidewire, coaxial catheter, and a guiding catheter; CAS was performed with distal filter protection. Before removal of the sheath, the right iliac artery was examined, and extraversation of the contrast medium was observed. The balloon catheter was placed to the lesion and dilated for the hemostasis. However, it failed, and the covered stent was placed subsequently. Although blood tests revealed anemia and CT showed retroperitoneal hematoma after the treatment, further complication did not occur. Treatment with covered stent for the vessel injury was effective.
Subject(s)
Carotid Stenosis/therapy , Iliac Artery/injuries , Iliac Artery/surgery , Intraoperative Complications/therapy , Stents , Vascular System Injuries/therapy , Aged , Angiography , Carotid Artery, Common/diagnostic imaging , Catheterization, Peripheral/adverse effects , Catheterization, Peripheral/methods , Humans , Iliac Artery/diagnostic imaging , Male , Premedication , Vascular System Injuries/diagnostic imaging , Vascular System Injuries/etiologyABSTRACT
OBJECTIVE: Carotid artery stenting (CAS) is a well-accepted treatment for atherosclerotic stenosis of carotid arteries. Since the occurrence of distal embolization with CAS is still a major concern embolus protection devices (EPD) are usually employed during the procedure. We examined two types of embolus protection filters (Angioguard XP (AG); Filterwire EZ (FW)) and evaluated the function. Thus, the filter was examined postoperatively and the cause of intraoperative flow impairment was evaluated. MATERIALS AND METHODS: CAS was performed for 54 patients with carotid artery stenosis (55 lesions: 25 AG; 27 FW; 3 others). After completing CAS the filter membrane was stained with hematoxylin-eosin (HE) solution and removed from the filter strut. Once mounted on a glass slide the filter was evaluated under a microscope. The area occupied with debris was measured and the relationship to intraoperative flow impairment was evaluated. Furthermore, the relationship between perioperative ischemic complications and intraoperative flow impairment was statistically analyzed. RESULTS: Microscopic observation of the slide revealed the pore density of the FW was 1.5 times higher than that of the AG and the filter area of the FW was 2.5 times wider than than the AG. HE staining facilitated characterization of the debris composition. The area occupied with debris was significantly more in the AG (0.241 ± 0.13 cm(2)) than in the FW (0.129 ± 0.093 cm(2)). Thus, fibrin was significantly more precipitated in the AG. Flow impairment occurred in 6 AG cases (24.0 %) and 4 FW cases (14.8 %). It was induced by filter obstruction in the AG and by vasospasms in the FW. Three cases treated with AG (12.0 %) were complicated with cerebral infarction and all of them were related to flow impairment. One FW case (3.7 %) was complicated with cerebral infarction in presence of preserved flow throughout the intervention. CONCLUSION: Filter function is different according to each design. The cause of flow impairment was attributable to filter obstruction in the AG group and to vasospasms in the FW group. Filter obstruction tends to result in cerebral infarction.
Subject(s)
Carotid Stenosis/physiopathology , Carotid Stenosis/therapy , Intracranial Embolism/prevention & control , Intracranial Embolism/physiopathology , Aged , Brain Ischemia/physiopathology , Brain Ischemia/prevention & control , Cerebral Infarction/etiology , Embolic Protection Devices , Equipment Design , Filtration/instrumentation , Hemodynamics/physiology , Humans , Male , Microscopy , Middle Aged , Retrospective Studies , Stents/adverse effects , Stroke/etiologyABSTRACT
BACKGROUND: Cardiopulmonary dysfunction may occur after aneurysmal subarachnoid hemorrhage (SAH), but its characteristics have not been fully clarified. We investigated the impact of aneurysm location on systemic hemodynamics after SAH. METHODS: This multicenter prospective cohort study measured hemodynamic parameters in relation to aneurysm location in patients with SAH using a single-indicator transpulmonary thermodilution system (PiCCO) on days 1-14. RESULTS: Of 204 subjects enrolled, 58 had aneurysms of the anterior communicating artery (ACA), 61 of the middle cerebral artery (MCA), 57 of the internal carotid artery (ICA), and 28 of the vertebrobasilar artery (VA/BA). Patient characteristics were similar except for predominance of coiling in the VA/BA. Patients with ACA aneurysm had a lower systemic vascular resistance index (SVRI) in the acute phase and afterload mismatch (lower cardiac index [CI] and higher SVRI) in the spasm phase. Those with ICA aneurysm had a lower CI in the acute phase, and those with VA/BA aneurysm had a warm shock-like condition (higher CI and lower SVRI) in the spasm phase. Patients with MCA aneurysm showed no specific characteristics in CI and SVRI with a significant improvement in B-type natriuretic peptide. Extravascular lung water index was high independent of left cardiac dysfunction. In multivariate analysis, age and ACA were independently related to poor global ejection fraction after SAH. CONCLUSIONS: Aneurysm location affects cardiac output, vascular resistance, and pulmonary edema in biphasic fashion. Patient age and location of aneurysm in the ACA may be risk factors for cardiac failure after SAH.
Subject(s)
Heart Diseases/physiopathology , Lung Diseases/physiopathology , Subarachnoid Hemorrhage/physiopathology , Aged , Aneurysm, Ruptured/complications , Aneurysm, Ruptured/physiopathology , Cardiac Output , Female , Heart Diseases/etiology , Hemodynamics , Humans , Lung Diseases/etiology , Male , Middle Aged , Myocardial Contraction , Neurosurgical Procedures , Perioperative Care , Prospective Studies , Pulmonary Edema/pathology , Subarachnoid Hemorrhage/complications , Subarachnoid Hemorrhage/surgeryABSTRACT
BACKGROUND: The association between comprehensive stroke care capacity and hospital volume of stroke interventions remains uncertain. We performed a nationwide survey in Japan to examine the impact of comprehensive stroke care capacity on the hospital volume of stroke interventions. METHODS: A questionnaire on hospital characteristics, having tissue plasminogen activator (t-PA) protocols, and 25 items regarding personnel, diagnostic, specific expertise, infrastructure, and educational components recommended for comprehensive stroke centers (CSCs) was sent to 1369 professional training institutions. We examined the effect of hospital characteristics, having a t-PA protocol, and the number of fulfilled CSC items (total CSC score) on the hospital volume of t-PA infusion, removal of intracerebral hemorrhage, and coiling and clipping of intracranial aneurysms performed in 2009. RESULTS: Approximately 55% of hospitals responded to the survey. Facilities with t-PA protocols (85%) had a significantly higher likelihood of having 23 CSC items, for example, personnel (eg, neurosurgeons: 97.3% versus 66.1% and neurologists: 51.3% versus 27.7%), diagnostic (eg, digital cerebral angiography: 87.4% versus 43.2%), specific expertise (eg, clipping and coiling: 97.2% and 54% versus 58.9% and 14.3%, respectively), infrastructure (eg, intensive care unit: 63.9% versus 33.9%), and education (eg, professional education: 65.2% versus 20.7%). On multivariate analysis adjusted for hospital characteristics, total CSC score, but not having a t-PA protocol, was associated with the volume of all types of interventions with a clear increasing trend (P for trend < .001). CONCLUSION: We demonstrated a significant association between comprehensive stroke care capacity and the hospital volume of stroke interventions in Japan.
Subject(s)
Comprehensive Health Care/trends , Hospitals, High-Volume/trends , Hospitals, Low-Volume/trends , Outcome and Process Assessment, Health Care/trends , Stroke/therapy , Delivery of Health Care, Integrated/trends , Embolization, Therapeutic/trends , Fibrinolytic Agents/administration & dosage , Health Care Surveys , Health Services Accessibility/trends , Healthcare Disparities/trends , Humans , Japan , Linear Models , Multivariate Analysis , Neurosurgical Procedures/trends , Patient Care Team/trends , Stroke/diagnosis , Surveys and Questionnaires , Thrombolytic Therapy/trends , Tissue Plasminogen Activator/administration & dosage , Treatment OutcomeABSTRACT
OBJECTIVE: Here we report a case of carotid blowout syndrome (CBS) treated with parent artery occlusion using pushable coils. CASE PRESENTATION: A 68-year-old man with a history of surgery and chemoradiation therapy for esophageal cancer 9 years prior presented with a massive hemorrhage from a skin defect in the neck. Angiography revealed encasement of the right common carotid artery by radiation necrosis, and CBS was diagnosed. We performed emergent endovascular treatment, and the right common carotid artery was occluded using pushable coils and a detachable coil. The patient's postoperative course was uneventful. However, he died of esophageal cancer recurrence 6 months later. CONCLUSION: Pushable coils were useful for occluding the parent artery in this case of CBS.
Subject(s)
Carotid Artery Diseases/therapy , Carotid Artery, Internal/surgery , Embolization, Therapeutic , Aged , Angiography/methods , Brain Neoplasms/complications , Brain Neoplasms/pathology , Carotid Artery Diseases/diagnosis , Carotid Artery Diseases/etiology , Embolization, Therapeutic/methods , Fatal Outcome , Humans , Male , Skin/pathology , Treatment OutcomeABSTRACT
Here we report a case of radiation-induced carotid stenosis treated with carotid artery stenting and proximal and distal protection. A 62-year-old man with a history of radiation therapy for cervical malignant lymphoma at 31 years of age was diagnosed with left radiation-induced carotid stenosis. Angiography revealed left common carotid artery severe stenosis, and T1-weighted magnetic resonance imaging showed plaque hyperintensity. He was treated with carotid artery stenting and proximal and distal protection. Postoperative carotid ultrasonography showed moderate dilatation of the left common carotid artery and his postoperative course was uneventful. Carotid artery stenting and proximal and distal protection for radiation-induced carotid stenosis may be an effective treatment.
Subject(s)
Carotid Artery, Common/surgery , Carotid Stenosis/etiology , Carotid Stenosis/surgery , Stents , Vascular Surgical Procedures , Angioplasty, Balloon/methods , Carotid Artery, Common/diagnostic imaging , Humans , Magnetic Resonance Angiography/methods , Magnetic Resonance Imaging/methods , Male , Middle Aged , Radiotherapy/adverse effects , Treatment Outcome , UltrasonographyABSTRACT
BACKGROUND AND PURPOSE: Intra-arterial cell transplantation offers a novel therapeutic strategy for stroke; however, it remains unclear how the timing of cell administration affects cell distribution, brain repair processes, and functional recovery. Here, we investigate the hypothesis that the timing of cell transplantation changes the behavior of the cell graft and the host environment in a way that affects functional recovery. METHODS: Rats received human mesenchymal stem cells via the internal carotid artery at 1, 4, or 7 days (D1, D4, or D7) after middle cerebral artery occlusion and reperfusion. Animals were euthanized at various time points to assess cell distribution, infiltration of activated microglia, expression of brain-derived neurotrophic factor, reactive astrocytes, angiogenesis, and functional recovery. RESULTS: Human mesenchymal stem cells were widely distributed both in the peri-infarct and core in D1, and dominantly in the peri-infarct in D4. Very few cells were observed on D7. At day 7 poststroke, microglia activation was significantly suppressed in both the peri-infarct and core in D1, and predominantly in the peri-infarct in D4. At day 21 poststroke, brain-derived neurotrophic factor was widely distributed throughout the peri-infarct in D1 and D4, along with many reactive astrocytes and considerable angiogenesis. Motor function improved earlier in D1 and later in D4, but no recovery was obtained in D7. CONCLUSIONS: Our results indicate that intra-arterial cell transplantation provides timing-dependent cell distribution and poststroke functional recovery via a combination of neuroprotection, reactive astrocyte enhancement, and angiogenesis.